Publication Type:

Journal Article

Source:

Nanomedicine: Nanotechnology, Biology, and Medicine (2013)

URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-84890275437&partnerID=40&md5=b011bebb74221f1cab10755a726b35fa

Abstract:

<p>A multifunctional core-shell nanomedicine capable of inhibiting the migratory capacity of metastatic cancer cells followed by imparting cytotoxic stress by photodynamic action is reported. Based on in silico design, we have developed a core-shell nanomedicine comprising of &nbsp; 80 nm size poly(lactic-co-glycolic acid) (PLGA) nano-core encapsulating photosensitizer, m-tetra(hydroxyphenyl)chlorin (mTHPC), and &nbsp; 20 nm size albumin nano-shell encapsulating tyrosine kinase inhibitor, Dasatinib, which impair cancer migration. This system was prepared by a sequential process involving electrospray of polymer core and coacervation of protein shell. Cell studies using metastatic breast cancer cells demonstrated disruption of Src kinase involved in the cancer migration by albumin-dasatinib nano-shell and generation of photoactivated oxidative stress by mTHPC-PLGA nano-core. This unique combinatorial photo-chemo nanotherapy resulted synergistic cytotoxicity in &nbsp; 99% of the motility-impaired metastatic cells. This approach of blocking cancer migration followed by photodynamic killing using rationally designed nanomedicine is a promising new strategy against cancer metastasis. © 2013.</p>

Notes:

cited By (since 1996)0; Article in Press

Cite this Research Publication

G. L. Malarvizhi, Chandran, P., Retnakumari, A. P., Ramachandran, R., Gupta, N., Nair, S., and Koyakutty, M., “A rationally designed photo-chemo core-shell nanomedicine for inhibiting the migration of metastatic breast cancer cells followed by photodynamic killing”, Nanomedicine: Nanotechnology, Biology, and Medicine, 2013.